ctDNA Monitoring for Small Cell Lung Cancer: Ready for Prime Time?

被引：5
|
作者：
Pellini, Bruna [1 ,2 ]
Chaudhuri, Aadel A. [1 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA
[2] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Tampa, FL USA
[3] Washington Univ, Dept Radiat Oncol, Div Canc Biol, Sch Med, St Louis, MO USA
[4] Washington Univ, Div Biol & Biomed Sci, Sch Med, St Louis, MO USA
[5] Washington Univ, Dept Genet, Sch Med, St Louis, MO USA
[6] Washington Univ, Dept Biomed Engn, St Louis, MO USA
[7] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA
[8] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA
[9] Washington Univ, Sch Med, St Louis, MO USA
[10] Washington Univ, Sch Med, 4511 Forest Pk Ave, St Louis, MO 63108 USA
来源：
CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 12期
关键词：
DISEASE;
D O I：
10.1158/1078-0432.CCR-23-0420
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Small cell lung cancer (SCLC) is the deadliest form of lung cancer and has few precision medicine approaches available. A recent study analyzed circulating tumor DNA (ctDNA) in 33 patients with extensive-stage SCLC and showed that ctDNA levels and response patterns correlate strongly with clinical response and survival outcomes.See related article by Sivapalan et al., p. 2310
引用
收藏
页码：2176 / 2178
页数：3
相关论文
共 50 条
  • [1] Is Radiomics Ready for Prime Time in Managing Non-small Cell Lung Cancer?
    Al-Kasspooles, Mazin
    Wilkerson, Jordan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 4841 - 4842
  • [2] Surgery for limited-stage small cell lung cancer: ready for prime-time?
    Ernani, Vinicius
    Ganti, Apar Kishor
    JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 3576 - 3578
  • [3] Liquid biopsy in non-small cell lung cancer: Is it ready for prime time yet?
    Shrestha, Prajwol
    Lee, Jenny
    Kao, Steven
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (02) : E3 - E4
  • [4] Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?
    Brighenti, Matteo
    Petrelli, Fausto
    Barni, Sandro
    Conti, Barbara
    Sarti, Enrico
    Ratti, Margherita
    Panni, Stefano
    Passalacqua, Rodolfo
    Bersanelli, Melissa
    EUROPEAN JOURNAL OF CANCER, 2017, 79 : 149 - 151
  • [5] Lung Cancer Screening: Ready for Prime Time?
    Peres, Judy
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (02):
  • [6] Biomarkers with Predictive and Prognostic Function in Non-Small Cell Lung Cancer: Ready for Prime Time?
    Aggarwal, Charu
    Somaiah, Neeta
    Simon, George R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (07): : 822 - 832
  • [7] The "liquid biopsy" in non-small cell lung cancer-not quite ready for prime time use
    Qin, Angel
    Ramnath, Nithya
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S632 - S635
  • [8] Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer-Ready for Prime Time?
    Millie Das
    Mohamed H. K. Abdelmaksoud
    Billy W. Loo
    Nishita Kothary
    Current Treatment Options in Oncology, 2010, 11 : 24 - 35
  • [9] Alternatives to Surgery for Early Stage Non-Small Cell Lung Cancer-Ready for Prime Time?
    Das, Millie
    Abdelmaksoud, Mohamed H. K.
    Loo, Billy W., Jr.
    Kothary, Nishita
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2010, 11 (1-2) : 24 - 35
  • [10] Prognostic markers in lung cancer: is it ready for prime time?
    Zhu, Chang-Qi
    Tsao, Ming-Sound
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (03) : 149 - 158
12345